ImageneBio Ownership | Who Owns ImageneBio?

ImageneBio Ownership Summary

ImageneBio is owned by 18.44% institutional investors, 14.24% insiders, and 67.32% retail investors. Bvf inc/il is the largest institutional shareholder, holding 9.93% of IMA shares.

IMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ImageneBio	18.44%	14.24%	67.32%
Sector	Healthcare Stocks	232.80%	10.63%	-143.43%
Industry	Biotech Stocks	379.48%	10.37%	-289.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	1.11M	9.93%	$5.55M
Blue owl capital lp	959.34K	8.58%	$4.80M
Cable car capital	754.75K	6.75%	$3.77M
Omega fund management	455.36K	4.07%	$2.28M
Orbimed advisors	378.56K	3.39%	$1.89M
Rtw investments, lp	334.44K	2.99%	$1.67M
Vanguard group	238.00K	2.79%	$1.64M
Bml capital management	200.73K	1.80%	$1.00M
Blackrock funding, inc. /de	129.21K	1.16%	$646.07K
Citadel advisors	124.34K	1.11%	$621.73K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Omega fund management	455.36K	1.40%	$2.28M
Cable car capital	754.75K	1.30%	$3.77M
Blue owl capital lp	959.34K	1.29%	$4.80M
Bml capital management	200.73K	0.64%	$1.00M
Bvf inc/il	1.11M	0.18%	$5.55M
Rangeley capital	32.59K	0.16%	$162.95K
Nano cap new millennium growth fund l p	30.00K	0.14%	$150.00K
Aldebaran capital	18.57K	0.07%	$92.83K
Orbimed advisors	378.56K	0.04%	$1.89M
Rtw investments, lp	334.44K	0.02%	$1.67M

Top Buyers

Holder	Shares	% Assets	Change
Bvf inc/il	1.11M	0.18%	307.90K
Blue owl capital lp	959.34K	1.29%	135.55K
Cable car capital	754.75K	1.30%	110.82K
Citadel advisors	124.34K	0.00%	37.87K
Vanguard fiduciary trust	27.29K	-	27.29K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-878.52K
Atlas venture life science advisors	-	-	-377.81K
Monashee investment management	-	-	-91.62K
Squarepoint ops	-	-	-48.24K
Drw securities	-	-	-43.77K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	27.29K	-	27.29K	$136.43K
Hrt financial lp	13.91K	0.00%	13.91K	$69.00K
Vanguard global advisers	602.00	-	602.00	$3.01K
Citigroup	224.00	-	224.00	$1.12K
Caitong asset management	2.00	-	2.00	$10.00

Sold Out

Holder	Change
Federated hermes	-204.00
Fortitude family office	-400.00
Millennium management	-11.45K
Drw securities	-43.77K
Squarepoint ops	-48.24K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	13	-59.38%	1,572,270	-66.58%	18	0.61%	10	-68.75%	1	-
Sep 30, 2025	32	-	4,705,090	-	55	-	32	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 14, 2026	Bonita David P	-	Buy	$384.69
Apr 14, 2026	Bonita David P	-	Buy	$336.60
Apr 14, 2026	ORBIMED ADVISORS LLC	-	Buy	$336.60
Apr 14, 2026	ORBIMED ADVISORS LLC	-	Buy	$384.69
Dec 24, 2025	SLATTERY JOSEPH P	-	Buy	$95.84K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	4	-
2026 Q1	-	-
2025 Q4	1	-
2025 Q3	2	-
2010 Q4	-	-

IMA Ownership FAQ

Who Owns ImageneBio?

ImageneBio shareholders are primarily institutional investors at 18.44%, followed by 14.24% insiders and 67.32% retail investors. The average institutional ownership in ImageneBio's industry, Biotech Stocks , is 379.48%, which ImageneBio falls below.

Who owns the most shares of ImageneBio?

ImageneBio’s largest shareholders are Bvf inc/il (1.11M shares, 9.93%), Blue owl capital lp (959.34K shares, 8.58%), and Cable car capital (754.75K shares, 6.75%). Together, they hold 25.26% of ImageneBio’s total shares outstanding.

Does Blackrock own ImageneBio?

BlackRock is not among the top 10 institutional shareholders of ImageneBio.

Who is ImageneBio’s biggest shareholder by percentage of total assets invested?

Omega fund management is ImageneBio’s biggest shareholder by percentage of total assets invested, with 1.40% of its assets in 455.36K ImageneBio shares, valued at 2.28M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools